Literature DB >> 16282345

Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment.

Yukari Muguruma1, Takashi Yahata, Hiroko Miyatake, Tadayuki Sato, Tomoko Uno, Jobu Itoh, Shunichi Kato, Mamoru Ito, Tomomitsu Hotta, Kiyoshi Ando.   

Abstract

Hematopoiesis is maintained by specific interactions between both hematopoietic and nonhematopoietic cells. Whereas hematopoietic stem cells (HSCs) have been extensively studied both in vitro and in vivo, little is known about the in vivo characteristics of stem cells of the nonhematopoietic component, known as mesenchymal stem cells (MSCs). Here we have visualized and characterized human MSCs in vivo following intramedullary transplantation of enhanced green fluorescent protein-marked human MSCs (eGFP-MSCs) into the bone marrow (BM) of nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice. Between 4 to 10 weeks after transplantation, eGFP-MSCs that engrafted in murine BM integrated into the hematopoietic microenvironment (HME) of the host mouse. They differentiated into pericytes, myofibroblasts, BM stromal cells, osteocytes in bone, bone-lining osteoblasts, and endothelial cells, which constituted the functional components of the BM HME. The presence of human MSCs in murine BM resulted in an increase in functionally and phenotypically primitive human hematopoietic cells. Human MSC-derived cells that reconstituted the HME appeared to contribute to the maintenance of human hematopoiesis by actively interacting with primitive human hematopoietic cells.

Entities:  

Mesh:

Year:  2005        PMID: 16282345     DOI: 10.1182/blood-2005-06-2211

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  86 in total

Review 1.  Bone marrow mesenchymal stem cells: historical overview and concepts.

Authors:  Pierre Charbord
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

Review 2.  The Impact of Mesenchymal Stem Cells on Differentiation of Hematopoietic Stem Cells.

Authors:  Mahshid Saleh; Karim Shamsasanjan; Aliakbar Movassaghpourakbari; Parvin Akbarzadehlaleh; Zahra Molaeipour
Journal:  Adv Pharm Bull       Date:  2015-09-19

Review 3.  Establishment and regulation of the HSC niche: Roles of osteoblastic and vascular compartments.

Authors:  Suleyman Coskun; Karen K Hirschi
Journal:  Birth Defects Res C Embryo Today       Date:  2010-12

Review 4.  The stem cell niches in bone.

Authors:  Tong Yin; Linheng Li
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 5.  Mesenchymal stromal cells.

Authors:  Armand Keating
Journal:  Curr Opin Hematol       Date:  2006-11       Impact factor: 3.284

6.  Intramarrow injection of beta-catenin-activated, but not naive mesenchymal stromal cells stimulates self-renewal of hematopoietic stem cells in bone marrow.

Authors:  Ji Yeon Ahn; Gyeongsin Park; Jae Seung Shim; Jong Wook Lee; Il Hoan Oh
Journal:  Exp Mol Med       Date:  2010-02-28       Impact factor: 8.718

7.  The Stromal Activity of Mesenchymal Stromal Cells.

Authors:  Wolfgang Wagner; Rainer Saffrich; Anthony D Ho
Journal:  Transfus Med Hemother       Date:  2008-05-16       Impact factor: 3.747

Review 8.  Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation.

Authors:  Charalampos Pontikoglou; Frédéric Deschaseaux; Luc Sensebé; Helen A Papadaki
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

9.  Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks.

Authors:  Suling Liu; Christophe Ginestier; Sing J Ou; Shawn G Clouthier; Shivani H Patel; Florence Monville; Hasan Korkaya; Amber Heath; Julie Dutcher; Celina G Kleer; Younghun Jung; Gabriela Dontu; Russell Taichman; Max S Wicha
Journal:  Cancer Res       Date:  2011-01-11       Impact factor: 12.701

10.  Ras-proximate-1 GTPase-activating protein and Rac2 may play pivotal roles in the initial development of myelodysplastic syndrome.

Authors:  Xuejun Shao; Meihua Miao; Xiaofei Qi; Zixing Chen
Journal:  Oncol Lett       Date:  2012-05-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.